Drug Shortage Report for MAR-CIPROFLOXACIN
Report ID | 213720 |
Drug Identification Number | 02379694 |
Brand name | MAR-CIPROFLOXACIN |
Common or Proper name | Ciprofloxacin |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-12-18 |
Actual start date | |
Estimated end date | 2024-04-30 |
Actual end date | 2024-04-22 |
Shortage status | Resolved |
Updated date | 2024-04-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-04-23 | English | Compare |
v9 | 2024-04-22 | French | Compare |
v8 | 2024-04-22 | English | Compare |
v7 | 2024-04-15 | French | Compare |
v6 | 2024-04-15 | English | Compare |
v5 | 2024-02-06 | French | Compare |
v4 | 2024-02-06 | English | Compare |
v3 | 2023-12-19 | English | Compare |
v2 | 2023-12-18 | French | Compare |
v1 | 2023-12-18 | English | Compare |
Showing 1 to 10 of 10